Search alternatives:
point decrease » point increase (Expand Search)
mean decrease » a decrease (Expand Search)
ppm decrease » _ decrease (Expand Search), a decrease (Expand Search), nn decrease (Expand Search)
non decrease » nn decrease (Expand Search), note decreased (Expand Search), fold decrease (Expand Search)
point decrease » point increase (Expand Search)
mean decrease » a decrease (Expand Search)
ppm decrease » _ decrease (Expand Search), a decrease (Expand Search), nn decrease (Expand Search)
non decrease » nn decrease (Expand Search), note decreased (Expand Search), fold decrease (Expand Search)
-
661
-
662
Antibody and antigen responses by baseline anti-spike neutralizing response assay positivity.
Published 2025Subjects: -
663
Baseline patient characteristics across neutralizing monoclonal antibody trials.
Published 2025Subjects: -
664
-
665
-
666
Antibody and antigen responses to nMAb vs placebo day 1–90 for Tixagevimab/ Cilgavimab.
Published 2025Subjects: -
667
-
668
-
669
Antibody and antigen responses to nMAb vs placebo day 1–90 for Bamlanivimab.
Published 2025Subjects: -
670
-
671
-
672
-
673
-
674
-
675
-
676
-
677
-
678
-
679
-
680